Evaluation of APTIMA Combo 2 for cross-reactivity with oropharyngeal Neisseria species and other microorganisms.
Nagasawa
Zenzo
Z
Ikeda-Dantsuji
Yurika
Y
Niwa
Toshihiro
T
Miyakoshi
Hideo
H
Nagayama
Ariaki
A
D002690:Chlamydia Infections / Q000175:diagnosis*; D002692:Chlamydia trachomatis / Q000302:isolation & purification*; D006069:Gonorrhea / Q000175:diagnosis*; D006801:Humans; D025202:Molecular Diagnostic Techniques; D009296:Nasal Cavity / Q000382:microbiology; D009343:Neisseria / Q000302:isolation & purification; D009344:Neisseria gonorrhoeae / Q000302:isolation & purification*; D021141:Nucleic Acid Amplification Techniques; D009960:Oropharynx / Q000382:microbiology*; D012329:RNA, Bacterial / Q000032:analysis; D012335:RNA, Ribosomal / Q000032:analysis; D012680:Sensitivity and Specificity; D015231:Sexually Transmitted Diseases, Bacterial / Q000175:diagnosis / Q000382:microbiology
D012329:RNA, Bacterial; D012335:RNA, Ribosomal